标题
Progresses in treating agitation: a major clinical challenge in Alzheimer’s disease
作者
关键词
-
出版物
EXPERT OPINION ON PHARMACOTHERAPY
Volume 16, Issue 17, Pages 2581-2588
出版商
Informa Healthcare
发表日期
2015-09-21
DOI
10.1517/14656566.2015.1092520
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Advancements in the treatment of agitation in Alzheimer’s disease
- (2015) Inga M Antonsdottir et al. EXPERT OPINION ON PHARMACOTHERAPY
- Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: A randomized controlled trial
- (2015) G. A. H. van den Elsen et al. NEUROLOGY
- A multicenter, randomized, double-blind, controlled phase 3 trial of fixed-dose brexpiprazole for the treatment of adults with acute schizophrenia
- (2015) John M. Kane et al. SCHIZOPHRENIA RESEARCH
- Principles and management of neuropsychiatric symptoms in Alzheimer’s dementia
- (2015) Milap A Nowrangi et al. Alzheimers Research & Therapy
- Neuropsychiatric symptoms in dementia—A role for neuroinflammation?
- (2014) Simon Holmgren et al. BRAIN RESEARCH BULLETIN
- Galantamine versus Risperidone for Agitation in People with Dementia: A Randomized, Twelve-Week, Single-Center Study
- (2014) Yvonne Freund-Levi et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Amyloid-directed monoclonal antibodies for the treatment of Alzheimer’s disease: the point of no return?
- (2014) Francesco Panza et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- START (STrAtegies for RelaTives) study: a pragmatic randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of a manual-based coping strategy programme in promoting the mental health of carers of people with dementia
- (2014) Gill Livingston et al. HEALTH TECHNOLOGY ASSESSMENT
- Medication development for agitation and aggression in Alzheimer disease: review and discussion of recent randomized clinical trial design
- (2014) Maria Soto et al. INTERNATIONAL PSYCHOGERIATRICS
- Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition
- (2014) Jeffrey Cummings et al. INTERNATIONAL PSYCHOGERIATRICS
- Effect of Citalopram on Agitation in Alzheimer Disease
- (2014) Anton P. Porsteinsson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Management of Neuropsychiatric Symptoms of Dementia in Clinical Settings: Recommendations from a Multidisciplinary Expert Panel
- (2014) Helen C. Kales et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Changes in QTc Interval in the Citalopram for Agitation in Alzheimer's Disease (CitAD) Randomized Trial
- (2014) Lea T. Drye et al. PLoS One
- Neuropsychiatric symptoms in Alzheimer's disease: Past progress and anticipation of the future
- (2013) Yonas E. Geda et al. Alzheimers & Dementia
- Galantamine Versus Risperidone Treatment of Neuropsychiatric Symptoms in Patients with Probable Dementia: An Open Randomized Trial
- (2013) Yvonne Freund-Levi et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Dronabinol for the Treatment of Agitation and Aggressive Behavior in Acutely Hospitalized Severely Demented Patients with Noncognitive Behavioral Symptoms
- (2013) Matthew R. Woodward et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- The Long-Term Effects of Conventional and Atypical Antipsychotics in Patients With Probable Alzheimer’s Disease
- (2013) Oscar L. Lopez et al. AMERICAN JOURNAL OF PSYCHIATRY
- Mibampator (LY451395) randomized clinical trial for agitation/aggression in Alzheimer's disease
- (2012) Paula T. Trzepacz et al. INTERNATIONAL PSYCHOGERIATRICS
- Nonpharmacologic Management of Behavioral Symptoms in Dementia
- (2012) Laura N. Gitlin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Relapse Risk after Discontinuation of Risperidone in Alzheimer's Disease
- (2012) D.P. Devanand et al. NEW ENGLAND JOURNAL OF MEDICINE
- Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
- (2012) Robert Howard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease
- (2011) Francesco Panza et al. AGEING RESEARCH REVIEWS
- Efficacy and Comparative Effectiveness of Atypical Antipsychotic Medications for Off-Label Uses in Adults
- (2011) Alicia Ruelaz Maher et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Randomized, Controlled Crossover Trial of Dronabinol, 2.5 mg, for Agitation in 2 Patients With Dementia
- (2011) Sebastian Walther et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Management of behavioral problems in Alzheimer's disease
- (2010) Serge Gauthier et al. INTERNATIONAL PSYCHOGERIATRICS
- Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine
- (2009) Joanne Rodda et al. INTERNATIONAL PSYCHOGERIATRICS
- Mild Behavioral Impairment and Risk of Dementia
- (2009) Fernando E. Taragano et al. JOURNAL OF CLINICAL PSYCHIATRY
- The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial
- (2009) Clive Ballard et al. LANCET NEUROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started